According to the UnivDatos, the surge in the incidence of PAH cases and the rise in demand for personalized medicine will drive the global scenario of Pulmonary Arterial Hypertension. As per their “Pulmonary Arterial Hypertension Market” report, the global market was valued at USD 7.5 billion in 2023, growing at a CAGR of about 5% during the forecast period from 2024 - 2032 to reach...